Page last updated: 2024-08-25

rosiglitazone and Bacteroidaceae Infections

rosiglitazone has been researched along with Bacteroidaceae Infections in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, S; Lei, L; Li, H; Pan, S; Yan, F	1

Other Studies

1 other study(ies) available for rosiglitazone and Bacteroidaceae Infections

Article	Year
Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice. International immunopharmacology, 2014, Volume: 23, Issue:2 Topics: Animals; Apolipoproteins E; Atherosclerosis; Bacteroidaceae Infections; Cytokines; Down-Regulation; Lipids; Male; Mice, Knockout; NF-kappa B; Porphyromonas gingivalis; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptors	2014

Article

Year

Rosiglitazone impedes Porphyromonas gingivalis-accelerated atherosclerosis by downregulating the TLR/NF-κB signaling pathway in atherosclerotic mice.

International immunopharmacology, 2014, Volume: 23, Issue:2

Topics: Animals; Apolipoproteins E; Atherosclerosis; Bacteroidaceae Infections; Cytokines; Down-Regulation; Lipids; Male; Mice, Knockout; NF-kappa B; Porphyromonas gingivalis; PPAR gamma; Rosiglitazone; Signal Transduction; Thiazolidinediones; Toll-Like Receptors

2014